Compare · MDLN vs OBLN
MDLN vs OBLN
Side-by-side comparison of Medline Inc. (MDLN) and Obalon Therapeutics, Inc. (OBLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and OBLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $46.86B.
- MDLN has hit the wire 12 times in the past 4 weeks while OBLN has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for OBLN).
- Company
- Medline Inc.
- Obalon Therapeutics, Inc.
- Price
- $35.64+2.77%
- $2.77-14.24%
- Market cap
- $46.86B
- -
- 1M return
- -10.28%
- -
- 1Y return
- -12.54%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2016
- News (4w)
- 12
- 0
- Recent ratings
- 25
- 0
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
Latest OBLN
- Obalon Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Obalon Therapeutics, Inc. (Amendment)
- SEC Form SC 13D/A filed by Obalon Therapeutics, Inc. (Amendment)
- SEC Form 4 filed by ARMISTICE CAPITAL, LLC
- SEC Form SC 13D filed by Obalon Therapeutics, Inc.
- SEC Form 3: STANKOVICH THOMAS claimed ownership of 2,613 units of Common Stock
- SEC Form 3 filed by McDougal Lori Courtney
- SEC Form 3 filed by GLADNEY DAN W
- SEC Form 3 filed by MINOCHERHOMJEE ARDA PHD
- SEC Form 3 filed by Bandy Barton P.